Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari Germans Trias i Pujol (14)

2024

  1. Association between endocrine and neuropsychological endophenotypes and gambling disorder severity

    Addictive Behaviors, Vol. 153

  2. Cluster analysis in gambling disorder based on sociodemographic, neuropsychological, and neuroendocrine features regulating energy homeostasis

    Comprehensive Psychiatry, Vol. 128

  3. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

2023

  1. Plasma concentration of leptin is related to food addiction in gambling disorder: Clinical and neuropsychological implications

    Journal of Behavioral Addictions, Vol. 12, Núm. 4, pp. 1019-1031

2022

  1. Are Signals Regulating Energy Homeostasis Related to Neuropsychological and Clinical Features of Gambling Disorder? A Case–Control Study

    Nutrients, Vol. 14, Núm. 23

  2. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  3. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

2021

  1. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    European Eating Disorders Review

  2. Molecular profiling for acromegaly treatment: a validation study

    Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389

2018

  1. Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852